Related Experiment Video
Updated: Jul 12, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.2K
A nomogram prognostic model for diffuse large B-cell lymphoma based on SUVmax and GNRI in elderly patients
Maoqin Li1, Haihao Lu1, Jiaoyang Fan1
1Department of Hematology The First Affiliated Hospital of Sun Yat-sen University Guangzhou P. R. China.
Ejhaem
|November 29, 2023
Summary
A new nomogram using imaging and nutritional markers improves risk prediction for elderly diffuse large B-cell lymphoma (DLBCL) patients. This tool offers superior survival stratification compared to existing models like NCCN-IPI.
Area of Science:
- Oncology
- Medical Imaging
- Geriatrics
Background:
- Diffuse large B-cell lymphoma (DLBCL) is a common non-Hodgkin lymphoma.
- Accurate prognostic models are crucial for elderly DLBCL patients.
- Existing models may not fully capture the complexities of this patient group.
Purpose of the Study:
- To develop and validate a nomogram for predicting survival in elderly DLBCL patients.
- To integrate nutritional and imaging features into a prognostic tool.
- To compare the nomogram's performance against established indices like IPI and NCCN-IPI.
Main Methods:
- Retrospective analysis of 221 elderly, pretreated DLBCL patients.
- Data split into training and validation cohorts.
- Multivariate analysis to identify key prognostic factors: SUVmax, GNRI, and lactate dehydrogenase.
Main Results:
- A nomogram incorporating SUVmax and GNRI was established.
- The nomogram demonstrated good predictive accuracy (C-index: 0.772 training, 0.729 validation).
- The new model outperformed IPI and NCCN-IPI in risk stratification and clinical effectiveness.
Conclusions:
- The developed nomogram provides a superior prognostic tool for elderly DLBCL patients.
- Integrating imaging (SUVmax) and nutritional (GNRI) data enhances risk stratification.
- This model aids in personalized treatment strategies for this vulnerable population.
